Thrombomodulin levels during normal pregnancy, at delivery and in the postpartum: Comparison with tissue-type plasminogen activator and plasminogen activator inhibitor-1

Thrombosis and Haemostasis

Volumn 79, Issue 3, 1998, Pages 554-556

  De Moerloose, P ^a   Mermillod, N ^a   Amiral, J ^b   Reber, G ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b Serbio   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CONTROLLED STUDY; DELIVERY; ECLAMPSIA; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUERPERIUM; SECOND TRIMESTER PREGNANCY; THIRD TRIMESTER PREGNANCY;

EID: 0031910006     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1614943     Document Type: Article

References (22)

1. Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-6.
2. Ishii H, Majerus PW. Thrombomodulin is present in plasma and urine. J Clin Invest 1985; 76: 2178-81.
3. Boffa M-C. Considering cellular thrombomodulin distribution and its modulating factors can falicitate the use of plasma thrombomodulin as a reliable endothelial marker. Haemostasis 1996; Suppl 4: 233-43.
4. Minakami H, Takahashi T, Izumi A, Tamada T. Increased levels of plasma thrombomodulin in preeclampsia. Gynecol Obstet Invest 1993; 36: 208-10.
5. Hsu C-D, Copel J, Hong S-F, Chan DW. Thrombomodulin levels in preeclampsia, gestational hypertension, and chronic hypertension. Obstet Gynecol 1995; 86: 897-9.
6. Bontis J, Vavilis D, Agoratos T, Zournatzi V, Konstantinidis T, Tagou K. Maternal plasma level of thrombomodulin is increased in mild preeclampsia. Eur J Obstet Gynecol 1995; 60: 139-41.
7. Shaarawy M, El Didy H. Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia. Int J Gynecol Obstet 1996; 55: 135-9.
8. Hellgern M, Blombäck M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. Gynecol Obstet Invest 1981; 12: 141-54.
9. Stirling Y, Woolf L, North WR, Seghatchian MJ, Meade TW. Haemostasis in pregnancy. Thromb Haemost 1984; 52: 176-82.
10. Kruithof EKO, Tran-Thang C, Gudinchet A, Hauert J, Nicoloso G, Genton C, Welti H, Bachmann F. Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors. Blood 1987; 69: 460-6.
11. Mackinnon S, Walker ID, Davidson JF, Walker JJ. Plasma fibrinolysis during and after normal childbirth. Br J Haematol 1987; 65: 339-42.
12. Estelles A, Gilabert J, Aznar J, Loskutoff DJ, Schleef RR. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe pre-eclampsia. Blood 1989; 74: 1332-8.
13. Bonnar J, Daly L, Sheppard BL. Changes in the fibrinolytic system during pregnancy. Semin Thromb Haemostas 1990; 16: 221-9.
14. van Wersh JW, Ubachs JM. Blood coagulation and fibrinolysis during pregnancy. Eur J Clin Chem Clin Biochem 1991; 29: 45-50.
15. Bremme K, Ostlund E, Almqvist I, Heinonen K, Blombäck M. Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium. Obstet Gynecol 1992; 80: 132-7.
16. Reith A, Booth N, Moore NR, Cruickshank DJ, Bennett B. Plasminogen activator inhibitors (PAI-1 and PAI-2) in normal pregnancies, preeclampsia and hydatidiform mole. Br J Obstet Gynecol 1993; 100: 370-4.
17. Halligan A, Bonnar J, Sheppard B, Darling M, Walshe J. Haemostatic, fibrinolytic and endothelial variables in normal pregnancies and pre-eclampsia. Br J Obstet Gynecol 1994; 101: 488-92.
18. Sorensen JD, Secher NJ, Jespersen J. Perturbed (procoagulant) endothelium and deviations within the fibrinolytic system during the third trimester of normal pregnancy. Acta Obstet Gynecol Scand 1995; 74: 257-61.
19. Amiral J, Adam M, Mimilia F, Larrivaz I, Chambrette B, Boffa MC. Design and validation of a new immunoassay for soluble forms of thrombomodulin and studies in plasma. Hybridoma 1994; 13: 205-13.
20. Ballegeer V, Mombaerts P, Declerck PJ, Spitz B, Van Assche FA, Collen D. Fibrinolytic response to venous occlusion and fibrin fragment D-dimer levels in normal and complicated pregnancy. Thromb Haemost 1987; 58: 1030-2.
21. Cadroy Y, Grandjean H, Pichon J, Desprats R, Berrebi A, Fournié A, Boneu B. Evaluation of six markers of haemostatic system in normal pregnancy and pregnancy complicated by hypertension or pre-eclampsia. Br J Obstet Gynecol 1993; 100: 416-20.
22. Wright JG, Cooper P, Astedt B, Lecander I, Wilde JT, Preston FE, Greaves M. Fibrinolysis during normal human pregnancy: complex interrelationships between plasma levels of tissue plasminogen activator and inhibitors and the euglobulin clot lysis time. Br J Haematol 1988; 69: 253-8.